"HEB" Hemispherx BioPharma.... 第二帖

股龙

没有人回答我195楼的帖？
Poems 看不到AMEX哦？？？

m.i.k.e

原帖由 股龙 于 24-8-2009 07:10 PM 发表
没有人回答我195楼的帖？
Poems 看不到AMEX哦？？？

你login 后,要选 LP2 (在上面找一找, 第二行).

然后,在第四行,就会看到 AMEX.....click on it.

这 是real time 的价.

你之前看不到 AMEX, 应该是你选看 PRICE, 这个是 Delay 的价....每隔几分钟才 refresh 一次.

股龙

多谢多谢！！！

m.i.k.e

手头上有之前买入的IMMU, 赚幅肯定是有了....
所以有"股"无恐,昨晚就敢敢来......

Historical Trades

Action

Ref No.

Exch

Exec. Code

Stock Name

Side

Pymt

Traded Curr

Sett. Curr

Avg. Fill price$

Order Qty

Match Qty

Status

Modified Date & Time

Via

101000754096

NMS

IMMU

IMMUNOMEDICS

SELL

CASH

USD

SGD

6.88000

2,000

2,000

Filled

28-08-2009 03:50:14

CLT

101000752584

NMS

IMMU

IMMUNOMEDICS

BUY

CASH

USD

SGD

6.35000

2,000

2,000

Filled

27-08-2009 21:58:33

CLT

Immunomedics Posts Q4 Profit - Update
8/27/2009 7:30 PM  ET   

(RTTNews) -  Thursday, Immunomedics, Inc. (IMMU: News ), reported a turn to profit for the fourth quarter from a loss last year, benefiting from higher sales due to improved license revenues and lower expenses.

Immunomedics' net income for the fourth quarter was $0.85 million or $0.01 per share, compared to a loss of $6.95 million or $0.09 per share in the previous year.

Total revenues for the quarter increased to $8.30 million from $0.96 million a year ago primarily due to the $7.3 million license fee revenue from the company's development, collaboration and license agreement with Nycomed GmbH.

Total costs and expenses for the quarter declined to $5.85 million from $7.10 million last year. The lower expenses were primarily due to a $1.0 million reimbursement from Nycomed and no reimbursement in the comparable quarter last fiscal year.

eldersister

现在进场如何？

m.i.k.e

原帖由 eldersister 于 28-8-2009 03:22 PM 发表
现在进场如何？

IMMU 6.84
+2.58 (60.56%)

昨天已经升了60%, 你说风险是不是高了?

股龙

哇！！今天冲到很劲！！

TheMuppet

大家的ampliken被approve了吗???

葉芬

原帖由 TheMuppet 于 15-9-2009 02:31 PM 发表
大家的ampliken被approve了吗???

你的LVS放了嗎？








Time take profit....REMEMBER" when people become greedy,................."

[ 本帖最后由 葉芬 于 15-9-2009 02:59 PM 编辑 ]

TheMuppet

谢谢你的提醒! 目前没任何放掉的理由. 你认为有吗??

葉芬小姐你有CIMB GK的资料吧? 能不能现一份给我啊?? 我有兴趣.

葉芬

原帖由 TheMuppet 于 15-9-2009 06:15 PM 发表
谢谢你的提醒! 目前没任何放掉的理由. 你认为有吗??

葉芬小姐你有CIMB GK的资料吧? 能不能现一份给我啊?? 我有兴趣.

詳情 PM 你了。。

napster

Norvatis 的产品被approved 了。
HEB 的大炮太响了。


http://sg.news.yahoo.com/afp/20090916/tts-health-flu-us-vaccine-authorization-972e412.html

WASHINGTON (AFP) - - US drug regulators approved a swine flu vaccine on Tuesday, keeping officials on track to begin a mass vaccination campaign by next month, Health Secretary Kathleen Sebelius said.

"I am pleased to report that today, the Food and Drug Administration (FDA) has approved applications for vaccine for the 2009 H1N1 virus for four of the (five) manufacturers of the US licensed seasonal influenza vaccine," Sebelius told US lawmakers.
FDA Commissioner Margaret Hamburg welcomed the approval in a statement.
"Today's approval is good news for our nation's response to the 2009 H1N1 influenza virus," she said. "This vaccine will help protect individuals from serious illness and death from influenza."
The vaccine treatments are produced by CSL Limited, MedImmune LLC, Novartis Vaccines and Diagnostics Limited, and Sanofi Pasteur Inc, and the FDA said all four firms use the same processes.
The US government has purchased 195 million doses of swine flu vaccine and will make shots against the influenza A(H1N1) virus available free of charge starting next month, Sebelius said, although providers might charge a fee to administer them.
"The large-scale 2009 H1N1 vaccine program will begin mid-October with small amounts of vaccine becoming available the first week of October," she said.
The fifth US manufacturer was also expected to be licensed, she added.
Preliminary data from clinical studies showed the approved vaccines "induce a robust immune response in most healthy adults eight to 10 days after a single dose," the FDA said, noting that clinical studies underway would determine the best dose for children.
Vaccination will be on a voluntary basis, with priority given to five groups deemed to be at particular risk from the novel swine flu virus.

[ 本帖最后由 napster 于 16-9-2009 11:48 AM 编辑 ]

小鋒

原帖由 napster 于 16-9-2009 11:47 AM 发表
Norvatis 的产品被approved 了。
HEB 的大炮太响了。


http://sg.news.yahoo.com/afp/20090916/tts-health-flu-us-vaccine-authorization-972e412.html

WASHINGTON (AFP) - - US drug regulators approved a ...

其实不只是HEB啦。。
不过说回来，Ampligen的潜能是很不错的（光看啦，因为不是scientist)，就算不用在vaccine，其他方面相信也会有很显著的效果。。。只是何年何月才会有结果呢？

nggeewai

对heb 是好是坏？　

葉芬

HEB Technical Analysis - The following is Hemispherx Biopharma, Inc. (HEB) stock technical analysis for September 28, 2009

Hemispherx Biopharma, Inc. (HEB) Support & Resistance Levels - 9/28/09

Resistance Levels: $2.25, $2.54

Support Levels: $2.00, $1.86






HEB stock continues to hover around the $2 level. The company expects the FDA to come out with a decision on their CFS drug sometime this fall.

Resistance is located around $2.24, if I see HEB close above $2.25, I will get back into the stock. This would be a huge trend reversal because HEB hasn't closed over $2.25 since July.

On the downside, pullbacks to $1.86 must continue to hold.

miku

芬，你对heb还有信心吗？

葉芬

原帖由 miku 于 29-9-2009 01:34 AM 发表
芬，你对heb还有信心吗？

從一開始我買進HEB就有抱著一些賭博心態來看她。。。
到今天還是一樣。

葉芬

http://daytradingstockblog.blogs ... october-5-2009.html


Hemispherx Biopharma, Inc. (HEB) - I continue to keep HEB on my radar due to the possibility that the company is going to receive an FDA decision on CFS drug Ampligen sometime this fall. The FDA decision has been delayed over 4 months so far. Some say, the company is making everything up. Only time will tell.

miku

秋天几时完？十月不是鬼佬的冬天了吗？

m.i.k.e

HEB
Hemispherx BioPharma, Inc. Oct. 8, 2009 Market Close: $ 1.95

After Hours Last:	$ 2.16	After Hours High:	$ 2.20
After Hours Volume:	916,049	After Hours Low:	$ 1.95

After Hours Time (ET)	After Hours Price	After Hours Share Volume
19:37	$ 2.16	3,400
19:37	$ 2.16	185
19:37	$ 2.16	500
19:37	$ 2.16	500
19:37	$ 2.16	415
19:37	$ 2.17	250
19:36	$ 2.17	1,000
19:36	$ 2.17	1,000
19:36	$ 2.17	100
19:34	$ 2.16	1,000
19:31	$ 2.16	2,000
19:30	$ 2.16	500
19:30	$ 2.16	315
19:29	$ 2.16	300
19:29	$ 2.16	200
19:29	$ 2.16	500
19:27	$ 2.16	2,775
19:27	$ 2.16	500
19:27	$ 2.16	14,900
19:27	$ 2.16	100
19:27	$ 2.16	2,485
19:27	$ 2.16	7,188
19:27	$ 2.16	2,000
19:26	$ 2.16	4,000
19:26	$ 2.16	2,500
19:26	$ 2.16	8,200
19:26	$ 2.16	5,000
19:26	$ 2.17	615
19:26	$ 2.16	5,525
19:26	$ 2.16	1,500
19:26	$ 2.16	5,000
19:25	$ 2.17	2,000
19:25	$ 2.17	600
19:25	$ 2.16	4,900
19:25	$ 2.17	2,975
19:25	$ 2.18	450
19:25	$ 2.16	9,454
19:25	$ 2.16	500
19:24	$ 2.18	570
19:24	$ 2.18	230
19:24	$ 2.18	500
19:24	$ 2.18	1,000
19:24	$ 2.17	1,000
19:23	$ 2.17	525
19:23	$ 2.17	475
19:23	$ 2.17	2,025
19:21	$ 2.17	600
19:21	$ 2.17	875
19:20	$ 2.17	1,100
19:20	$ 2.17	400